Release of recombinant human interleukin-2 from dextran-based hydrogels
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 78 (1-3) , 1-13
- https://doi.org/10.1016/s0168-3659(01)00483-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hydrogels in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheresPublished by Elsevier ,1997
- Structure and solubility of interleukin‐2 in sodium dodecyl sulfateInternational Journal of Peptide and Protein Research, 1994
- Reconstitution of recombinant interleukin-2 (rIL-2): a comparative study of various rIL-2 muteinsEuropean Journal Of Cancer, 1993
- Oxidation of methionine residues of recombinant human interleukin 2 in aqueous solutions.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discsJournal of Controlled Release, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976